BCL2 and lung cancer: You et al.11 demonstrated that niclosamide not only prevented acquired radioresistance in vitro and in vivo but also stopped the activation of the STAT3/Bcl-2/Bcl-xL pathway caused by ionizing radiation in both radiosensitive and radioresistant human lung cancer cells11,32.